Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. / Koopmann, Matthew C; Nelson, David W; Murali, Sangita G; Liu, Xiaowen; Brownfield, Mark S; Holst, Jens Juul; Ney, Denise M.

I: Journal of Parenteral and Enteral Nutrition, Bind 32, Nr. 3, 30.04.2008, s. 254-65.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Koopmann, MC, Nelson, DW, Murali, SG, Liu, X, Brownfield, MS, Holst, JJ & Ney, DM 2008, 'Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats', Journal of Parenteral and Enteral Nutrition, bind 32, nr. 3, s. 254-65. https://doi.org/10.1177/0148607108316198

APA

Koopmann, M. C., Nelson, D. W., Murali, S. G., Liu, X., Brownfield, M. S., Holst, J. J., & Ney, D. M. (2008). Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. Journal of Parenteral and Enteral Nutrition, 32(3), 254-65. https://doi.org/10.1177/0148607108316198

Vancouver

Koopmann MC, Nelson DW, Murali SG, Liu X, Brownfield MS, Holst JJ o.a. Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. Journal of Parenteral and Enteral Nutrition. 2008 apr. 30;32(3):254-65. https://doi.org/10.1177/0148607108316198

Author

Koopmann, Matthew C ; Nelson, David W ; Murali, Sangita G ; Liu, Xiaowen ; Brownfield, Mark S ; Holst, Jens Juul ; Ney, Denise M. / Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. I: Journal of Parenteral and Enteral Nutrition. 2008 ; Bind 32, Nr. 3. s. 254-65.

Bibtex

@article{c536d301aed84148bade5c6039ee6aac,
title = "Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats",
abstract = "BACKGROUND: Glucagon-like peptide-2 (GLP-2) is a nutrient-dependent proglucagon-derived hormone that stimulates intestinal adaptive growth. Our aim was to determine whether exogenous GLP-2 increases resection-induced adaptation without diminishing endogenous proglucagon and GLP-2 receptor expression.METHODS: Rats underwent transection or 70% jejunoileal resection +/- GLP-2 infusion (100 microg/kg body weight/d) and were fed a semipurified diet with continuous infusion of GLP-2 or saline by means of jugular catheter. After 7 days, body weight, mucosal cellularity (dry mass, protein and DNA), crypt-villus height, and crypt cell proliferation (by bromodeoxyuridine staining) were determined. Plasma bioactive GLP-2 (by radioimmunoassay), proglucagon and GLP-2 receptor mRNA expression (by Northern blot and real-time reverse transcriptase quantitative polymerase chain reaction) were measured. GLP-2 receptor was colocalized to neuroendocrine markers by immunohistochemistry.RESULTS: Low-dose exogenous GLP-2 increased mucosal cellularity and crypt-villus height in the duodenum, jejunum, and ileum; enterocyte proliferation in the jejunal crypt; and duodenal and jejunal sucrase segmental activity. Plasma bioactive GLP-2 concentration increased 70% upon resection, with an additional 54% increase upon GLP-2 infusion in resected rats (P < .05). Ileal proglucagon mRNA expression increased with resection, and exogenous ileum GLP-2 failed to blunt this response. Exogenous GLP-2 increased ileum GLP-2 receptor expression 3-fold in resected animals and was colocalized to vasoactive intestinal peptide-positive and endothelial nitric oxide synthase-expressing enteric neurons and serotonin-containing enteroendocrine cells in the jejunum and ileum of resected rats.CONCLUSIONS: Exogenous GLP-2 augments adaptive growth and digestive capacity of the residual small intestine in a rat model of mid-small bowel resection by increasing plasma GLP-2 concentrations and GLP-2 receptor expression without diminishing endogenous proglucagon expression.",
keywords = "Adaptation, Physiological, Animals, Cell Division, Disease Models, Animal, Enteral Nutrition, Glucagon-Like Peptide 2, Immunohistochemistry, Intestinal Mucosa, Intestine, Small, Male, Proglucagon, RNA, Messenger, Random Allocation, Rats, Rats, Sprague-Dawley, Receptors, Glucagon, Weight Gain",
author = "Koopmann, {Matthew C} and Nelson, {David W} and Murali, {Sangita G} and Xiaowen Liu and Brownfield, {Mark S} and Holst, {Jens Juul} and Ney, {Denise M}",
year = "2008",
month = apr,
day = "30",
doi = "10.1177/0148607108316198",
language = "English",
volume = "32",
pages = "254--65",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications",
number = "3",

}

RIS

TY - JOUR

T1 - Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats

AU - Koopmann, Matthew C

AU - Nelson, David W

AU - Murali, Sangita G

AU - Liu, Xiaowen

AU - Brownfield, Mark S

AU - Holst, Jens Juul

AU - Ney, Denise M

PY - 2008/4/30

Y1 - 2008/4/30

N2 - BACKGROUND: Glucagon-like peptide-2 (GLP-2) is a nutrient-dependent proglucagon-derived hormone that stimulates intestinal adaptive growth. Our aim was to determine whether exogenous GLP-2 increases resection-induced adaptation without diminishing endogenous proglucagon and GLP-2 receptor expression.METHODS: Rats underwent transection or 70% jejunoileal resection +/- GLP-2 infusion (100 microg/kg body weight/d) and were fed a semipurified diet with continuous infusion of GLP-2 or saline by means of jugular catheter. After 7 days, body weight, mucosal cellularity (dry mass, protein and DNA), crypt-villus height, and crypt cell proliferation (by bromodeoxyuridine staining) were determined. Plasma bioactive GLP-2 (by radioimmunoassay), proglucagon and GLP-2 receptor mRNA expression (by Northern blot and real-time reverse transcriptase quantitative polymerase chain reaction) were measured. GLP-2 receptor was colocalized to neuroendocrine markers by immunohistochemistry.RESULTS: Low-dose exogenous GLP-2 increased mucosal cellularity and crypt-villus height in the duodenum, jejunum, and ileum; enterocyte proliferation in the jejunal crypt; and duodenal and jejunal sucrase segmental activity. Plasma bioactive GLP-2 concentration increased 70% upon resection, with an additional 54% increase upon GLP-2 infusion in resected rats (P < .05). Ileal proglucagon mRNA expression increased with resection, and exogenous ileum GLP-2 failed to blunt this response. Exogenous GLP-2 increased ileum GLP-2 receptor expression 3-fold in resected animals and was colocalized to vasoactive intestinal peptide-positive and endothelial nitric oxide synthase-expressing enteric neurons and serotonin-containing enteroendocrine cells in the jejunum and ileum of resected rats.CONCLUSIONS: Exogenous GLP-2 augments adaptive growth and digestive capacity of the residual small intestine in a rat model of mid-small bowel resection by increasing plasma GLP-2 concentrations and GLP-2 receptor expression without diminishing endogenous proglucagon expression.

AB - BACKGROUND: Glucagon-like peptide-2 (GLP-2) is a nutrient-dependent proglucagon-derived hormone that stimulates intestinal adaptive growth. Our aim was to determine whether exogenous GLP-2 increases resection-induced adaptation without diminishing endogenous proglucagon and GLP-2 receptor expression.METHODS: Rats underwent transection or 70% jejunoileal resection +/- GLP-2 infusion (100 microg/kg body weight/d) and were fed a semipurified diet with continuous infusion of GLP-2 or saline by means of jugular catheter. After 7 days, body weight, mucosal cellularity (dry mass, protein and DNA), crypt-villus height, and crypt cell proliferation (by bromodeoxyuridine staining) were determined. Plasma bioactive GLP-2 (by radioimmunoassay), proglucagon and GLP-2 receptor mRNA expression (by Northern blot and real-time reverse transcriptase quantitative polymerase chain reaction) were measured. GLP-2 receptor was colocalized to neuroendocrine markers by immunohistochemistry.RESULTS: Low-dose exogenous GLP-2 increased mucosal cellularity and crypt-villus height in the duodenum, jejunum, and ileum; enterocyte proliferation in the jejunal crypt; and duodenal and jejunal sucrase segmental activity. Plasma bioactive GLP-2 concentration increased 70% upon resection, with an additional 54% increase upon GLP-2 infusion in resected rats (P < .05). Ileal proglucagon mRNA expression increased with resection, and exogenous ileum GLP-2 failed to blunt this response. Exogenous GLP-2 increased ileum GLP-2 receptor expression 3-fold in resected animals and was colocalized to vasoactive intestinal peptide-positive and endothelial nitric oxide synthase-expressing enteric neurons and serotonin-containing enteroendocrine cells in the jejunum and ileum of resected rats.CONCLUSIONS: Exogenous GLP-2 augments adaptive growth and digestive capacity of the residual small intestine in a rat model of mid-small bowel resection by increasing plasma GLP-2 concentrations and GLP-2 receptor expression without diminishing endogenous proglucagon expression.

KW - Adaptation, Physiological

KW - Animals

KW - Cell Division

KW - Disease Models, Animal

KW - Enteral Nutrition

KW - Glucagon-Like Peptide 2

KW - Immunohistochemistry

KW - Intestinal Mucosa

KW - Intestine, Small

KW - Male

KW - Proglucagon

KW - RNA, Messenger

KW - Random Allocation

KW - Rats

KW - Rats, Sprague-Dawley

KW - Receptors, Glucagon

KW - Weight Gain

U2 - 10.1177/0148607108316198

DO - 10.1177/0148607108316198

M3 - Journal article

C2 - 18443137

VL - 32

SP - 254

EP - 265

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 3

ER -

ID: 132049108